DINOPROSTONE
Background and Date of Approval
Dinoprostone is a uterotonic medication approved by the U.S. Food and Drug Administration, initially indicated for labour induction in pregnant women.
Uses
Dinoprostone is used to induce labor in pregnant women. It facilitates cervical ripening and manages certain pregnancy-related complications. It is a synthetic form of prostaglandin E2, a hormone that influences uterine contractions and cervical changes.
How is it administered?
Dinoprostone gel is administered intravaginally for the purpose of cervical ripening or labor induction. Using a sterile applicator, the physician gently inserts the gel into the patient's vagina and places it close to the cervix. After application, the patient is monitored for some time.
Side Effects
The side effects known to occur commonly during the treatment with Dinoprostone are uterine contractions, abdominal pain, nausea and vomiting, diarrhea, headache, and changes in blood pressure. Some serious side effects include severe abdominal pain, heavy vaginal bleeding, and signs of an allergic reaction (swelling, rash, itching, difficulty breathing).
Warnings
Before receiving Dinoprostone, it's important to inform your physician about any allergies, sensitivities, existing heart, lung, kidney, or liver disease, previous uterine surgeries, or cesarean sections in your medical history, as well as any ongoing use of medications, supplements, or herbal products. This information will help ensure the safe and effective use of the medication for your specific situation.
Precautions
This medicine can only be given in the later stages of pregnancy to induce labour. Consult your doctor for more advice. While this drug is found in breast milk, it poses no harm to your baby. Therefore, you can continue breastfeeding without concern after childbirth.
Word of Advice
Dinoprostone induces uterine contractions required for labour. Incorrect administration may result in excessive contractions or other complications. Proper dosing and clinical oversight are essential to ensure safe use.
References
Pfizer, Electronic medicines compendium (EMC), [ Revised on June 2021] [ Accessed on 26th August 2023], https://www.medicines.org.uk/emc/files/pil.1090.pdf Pfizer, US Food and Drug Administration, [ Revised on Feb 2010] [ Accessed on 26th August 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019617s010lbl.pdf KD Tripathi, Essentials of Medical Pharmacology, Prostaglandins, Leukotrienes and Platelet-activating factor, 7th edition, 2013, 189. Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Contraception and Pharmacotherapy of Obstetrical, 12th edition, 2011, 1850.
Frequently Asked Questions
How is Dinoprostone administered?
Dinoprostone can be administered in various forms, including vaginal suppositories, gels, and inserts. The specific form and dosage will depend on the medical condition being treated and the physician's recommendation.
Who should not use Dinoprostone?
Dinoprostone should be used with caution or avoided in individuals with a history of certain medical conditions, such as hypersensitivity to prostaglandins, a history of uterine surgery, previous cesarean section, or abnormal fetal heart rate. Pregnant individuals with certain medical complications may also not be suitable candidates for this drug.
Can Dinoprostone be used at home?
No, Dinoprostone is usually administered in a healthcare setting, such as a hospital, under the supervision of medical professionals due to its potential for causing strong uterine contractions and the need for monitoring.
How does Dinoprostone work?
Dinoprostone works by increasing uterine contractions and softening the cervix. It helps to prepare the cervix for labor and delivery.
Are there any side effects of Dinoprostone?
Some common side effects of Dinoprostone include uterine contractions, abdominal pain, nausea, vomiting, diarrhea, headache, and changes in blood pressure. Serious side effects are rare but can include allergic reactions and uterine rupture.